Bailey B. Banach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bailey B. Banach has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Eswar R. Reddem
Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA, 10027
3 shared publications - Gabriele Cerutti
Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
3 shared publications - Lawrence Shapiro
Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
3 shared publications Bimela J
2 shared publications- Brandon J. DeKosky
The Ragon Institute of Massachusetts General Brigham, Massachusetts Institute of Technology, and Harvard University, Cambridge, USA
2 shared publications DeKosky BJ
2 shared publications
Latest Publications
- Open Access
- 8 February 2024
- Published by EMBL-EBI
Single-particle cryo-EM unaligned micrographs of neutralizing antibody 910-30 in complex with SARS-CoV-2 spike glycoprotein (disrupted form)
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- 8 February 2024
- Published by EMBL-EBI
Open AccessSingle-particle cryo-EM unaligned micrographs of neutralizing antibody 910-30 in complex with SARS-CoV-2 spike glycoprotein (disrupted form)
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- Open Access
- 8 February 2024
- Published by EMBL-EBI
Single-particle cryo-EM unaligned micrographs of neutralizing antibody 910-30 in complex with prefusion SARS-CoV-2 spike glycoprotein
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- 8 February 2024
- Published by EMBL-EBI
Open AccessSingle-particle cryo-EM unaligned micrographs of neutralizing antibody 910-30 in complex with prefusion SARS-CoV-2 spike glycoprotein
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- Open Access
- 23 June 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (8)
Highly protective antimalarial antibodies via precision library generation and yeast display screening
The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturation mutagenesis and DNA shuffling to screen precise gene-variant yeast display libraries for improved PfCSP antigen recognition. We identified several mutations that improved recognition, predominately in framework regions, and combined these to produce a panel of antibody variants. The most improved antibody, CIS43_Var10, had three mutations and showed approximately sixfold enhanced protective potency in vivo compared to CIS43. Co-crystal and cryo-electron microscopy structures of CIS43_Var10 with the peptide epitope or with PfCSP, respectively, revealed functional roles for each of these mutations. The unbiased site-directed mutagenesis and screening pipeline described here represent a powerful approach to enhance protective potency and to enable broader clinical use of antimalarial antibodies.
- 23 June 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (8)
Open AccessHighly protective antimalarial antibodies via precision library generation and yeast display screening
The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturation mutagenesis and DNA shuffling to screen precise gene-variant yeast display libraries for improved PfCSP antigen recognition. We identified several mutations that improved recognition, predominately in framework regions, and combined these to produce a panel of antibody variants. The most improved antibody, CIS43_Var10, had three mutations and showed approximately sixfold enhanced protective potency in vivo compared to CIS43. Co-crystal and cryo-electron microscopy structures of CIS43_Var10 with the peptide epitope or with PfCSP, respectively, revealed functional roles for each of these mutations. The unbiased site-directed mutagenesis and screening pipeline described here represent a powerful approach to enhance protective potency and to enable broader clinical use of antimalarial antibodies.
- Open Access
- 28 September 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (1) , 109771
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
- 28 September 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (1) , 109771
Open AccessPaired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses